Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C21H30O3 |
| Molecular Weight | 330.4611 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 6 / 6 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
InChI
InChIKey=DJPZSBANTAQNFN-PXQJOHHUSA-N
InChI=1S/C21H30O3/c1-13(22)24-19-7-6-17-16-5-4-14-12-15(23)8-10-20(14,2)18(16)9-11-21(17,19)3/h12,16-19H,4-11H2,1-3H3/t16-,17-,18-,19-,20-,21-/m0/s1
Testosterone acetate, a testosterone ester, is an androgen. It is a steroid lipid molecule considered to be practically insoluble (in water) and basic. It is an anabolic steroid and testosterone prodrug. Testosterone acetate has a faster rate of absorption in the body then other esters. In combination with two other testosterone esters, testosterone valerate and testosterone undecanoate, it is a part of Deposterona, an injectable veterinary blend steroid preparation marketed in Mexico. With its blend of slow and fast-acting esters, Deposterona is essentially a low dosed alternative to Sustanon and is used primarily to treat impotence, weakness, fatigue, and hypogonadism in male breeding animals (cows, pigs, canines, and sheep), and also as a general protein-sparing anabolic. Testosterone acetate is classified as a Schedule III drug by the United States Drug Enforcement Agency and is only legal with a prescription due to his potential for misuse and abuse.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| 3alpha-androstanediol, but not testosterone, attenuates age-related decrements in cognitive, anxiety, and depressive behavior of male rats. | 2010 |
|
| An unusual ring--a opening and other reactions in steroid transformation by the thermophilic fungus Myceliophthora thermophila. | 2009-09 |
|
| Androgen-induced vocal transformation in adult female African clawed frogs. | 2005-07 |
|
| Comparison of crystal structures of human type 3 3alpha-hydroxysteroid dehydrogenase reveals an "induced-fit" mechanism and a conserved basic motif involved in the binding of androgen. | 2005-06 |
|
| Induction of androgen receptor activity by norgestimate and norelgestromin in MDA-MB 231 breast cancer cells. | 2004-07 |
|
| [The influence of pregnancy and hormone on the lymphatic stomata in guinea pig's ovary bursa]. | 2003-02 |
Patents
Sample Use Guides
For bodybuilding purposes, Deposterona (12mg of testosterone acetate, 12mg of testosterone valerate, and 36mg of testosterone undecanoate per milliliter of oil) is injected on at least a weekly basis, in a dosage of 120-360 mg (2-6 ml). Dividing the weekly dosage into two or more smaller applications can reduce injection volume. Cycles are generally between 6 and 12 weeks in length. This level is sufficient to provide noticeable gains in muscle size and strength.
Route of Administration:
Intravascular
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
m10594
Created by
admin on Mon Mar 31 19:53:44 GMT 2025 , Edited by admin on Mon Mar 31 19:53:44 GMT 2025
|
PRIMARY | Merck Index | ||
|
SUB130904
Created by
admin on Mon Mar 31 19:53:44 GMT 2025 , Edited by admin on Mon Mar 31 19:53:44 GMT 2025
|
PRIMARY | |||
|
213-876-6
Created by
admin on Mon Mar 31 19:53:44 GMT 2025 , Edited by admin on Mon Mar 31 19:53:44 GMT 2025
|
PRIMARY | |||
|
1045-69-8
Created by
admin on Mon Mar 31 19:53:44 GMT 2025 , Edited by admin on Mon Mar 31 19:53:44 GMT 2025
|
PRIMARY | |||
|
523836
Created by
admin on Mon Mar 31 19:53:44 GMT 2025 , Edited by admin on Mon Mar 31 19:53:44 GMT 2025
|
PRIMARY | |||
|
100000156833
Created by
admin on Mon Mar 31 19:53:44 GMT 2025 , Edited by admin on Mon Mar 31 19:53:44 GMT 2025
|
PRIMARY | |||
|
DTXSID80909007
Created by
admin on Mon Mar 31 19:53:44 GMT 2025 , Edited by admin on Mon Mar 31 19:53:44 GMT 2025
|
PRIMARY | |||
|
16524
Created by
admin on Mon Mar 31 19:53:44 GMT 2025 , Edited by admin on Mon Mar 31 19:53:44 GMT 2025
|
PRIMARY | |||
|
92145
Created by
admin on Mon Mar 31 19:53:44 GMT 2025 , Edited by admin on Mon Mar 31 19:53:44 GMT 2025
|
PRIMARY | |||
|
Testosterone acetate
Created by
admin on Mon Mar 31 19:53:44 GMT 2025 , Edited by admin on Mon Mar 31 19:53:44 GMT 2025
|
PRIMARY | |||
|
5652105Y6S
Created by
admin on Mon Mar 31 19:53:44 GMT 2025 , Edited by admin on Mon Mar 31 19:53:44 GMT 2025
|
PRIMARY | |||
|
C040594
Created by
admin on Mon Mar 31 19:53:44 GMT 2025 , Edited by admin on Mon Mar 31 19:53:44 GMT 2025
|
PRIMARY |
SUBSTANCE RECORD